https://www.selleckchem.com/pr....oducts/n-ethylmaleim
ogic remission comprised endoscopic score at week 8, FC concentration at week 8, and histologic activity at baseline and week8. A post hoc analysis of data from a phase 4 trial found that, even in patients with complete endoscopic healing of UC, FC concentration can be used to discriminate patients with ongoing microscopic inflammation from patients with histologic remission. The optimal cut-off concentration of FC is between 75 and 100 μg/g. ClinicalTrials.gov no NCT01124149. A post hoc analysis of data from a phase 4 tria
Gefällt mir
Kommentar
Teilen
